Here are relevant reports on : diagnostic-disinfectant-market
-
Needles Market by Type (Conventional (Bevel, Vented) & Safety), Product (Suture, Blood Collection, Insufflation), Material (Stainless Steel, Plastic), Delivery Mode (IV, IM, Hypodermic), End-User (Hospitals, Diagnostic Centres) & Region - Global Forecast to 2027
The global needles market growth is primed to transition from billion USD 7.7 in 2022 to USD 10.6 billion by 2027, showcasing a strong CAGR of 6.7%. The expansion of this market is majorly due to upsurging cases of chronic diseases such as cancer, HIV as well as growing elderly population. However, Growing focus on core development of substitute drug delivery methods is one of the challenge for which may inhibit the growth of this market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Cell Culture Equipment Market by Type (Supporting, Bioreactors, Storage), Application (Biopharma Production, Diagnostics, Tissue Engineering), End User (Pharma & Biotech Companies, Hospitals & Diagnostic Labs, Academia), Region - Global Forecast to 2031
The Cell Culture Equipment market, valued at USD 7.77 billion in 2025, stood at USD 8.36 billion in 2026 and is projected to advance at a resilient CAGR of 11.1% from 2026 to 2031, culminating in a forecasted valuation of USD 14.18 billion by the end of the period. Cell culture equipment encompasses the instruments used to grow and maintain cells in controlled laboratory environments for medical, research, and production purposes.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA, (CPG Oligos, gRNA)), Application (Therapeutic, Research, Diagnostic), End User (Pharma, Biotech) - Global Forecast to 2029
The global oligonucleotide CDMO market, valued at US$2.33 billion in 2023, stood at US$2.51 billion in 2024 and is projected to advance at a resilient CAGR of 21.8% from 2024 to 2029, culminating in a forecasted valuation of US$6.73 billion by the end of the period. The increasing focus on precision/personalized medicine is also likely to contribute to market growth. Growing opportunities offered by emerging economies are accelerating innovation in the oligonucleotide CDMO field.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Colposcopy Market by Instrument Type (Optical, Digital), Portability (Fixed, Portable, Handheld), Application (Cervical Cancer Diagnosis, Physical Examination), End User (Hospitals, Clinics, Diagnostic Centres), and Region - Global Forecasts to 2023
The global colposcopy market is projected to reach USD 740.1 Million by 2023, at a CAGR of 6.8%. Market growth can largely be attributed to factors such as the heavy burden of cervical cancer, the rapidly growing geriatric population, and technological advancements in colposcopy. Increasing awareness about gynecological diseases and the emerging Asian markets are expected to present a wide array of growth opportunities for players in the market. Key players in the Colposcopy market include DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Creatinine Measurement Market by Product (Kits, Reagents), Test Type (Jaffe method, Enzymatic creatinine method), Sample (Serum Creatinine, Urine) and End User (Hospitals, Diagnostic Laboratories), Region (North America, Europe) - Global Forecasts to 2023
The global creatinine measurement market is projected to reach USD 564.5 Million by 2023, at a CAGR of 8.4%. The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives. The creatinine measurement market is highly fragmented with the presence of several large as well as emerging players. Prominent players in this market include F. Hoffmann-la Roche Ltd (Switzerland)., Abbott Laboratories (US), Danaher Corporation (US), Thermo Fisher Scientific Inc (US), Siemens Healthineers (Germany), Randox Laboratories (UK)., Pointe Scientific, Inc (US), Sentinel Ch. Spa. (Italy), Diasys Diagnostic Systems GmbH (Germany), Dialab GmbH (Vienna), Diazyme Laboratories, Inc (US), Wako Pure Chemical Industries, Ltd. (Japan), Ortho Clinical Diagnostics (US), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
Minimal Residual Disease Market by Product (Kits, Instruments), Technology (PCR, NGS), Application (Leukemia, Lymphoma, Multiple Myeloma, Solid Tumors), End User (Hospitals, Diagnostic Labs, Research Institutes), & Region - Global Forecast to 2029
The global minimal residual disease testing market, valued at US$1.27 billion in 2023, stood at US$1.43 billion in 2024 and is projected to advance at a resilient CAGR of 12.2% from 2024 to 2029, culminating in a forecasted valuation of US$2.55 billion by the end of the period. The market is driven by the growing prevalence of cancer globally and increasing funding from international organizations and governments for cancer prevention programs.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Clinical Microbiology Market by Product (Instrument (Incubators), Analyzer (Microscope), Reagent, Kits, Media], Disease Area (Respiratory, Gastrointestinal, STD, UTI), End User (Hospitals, Diagnostic Center, Research Institutes) - Global Forecast to 2030
The global clinical microbiology market, valued at US$5.08 billion in 2024, stood at US$5.33 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$7.34 billion by the end of the period. A key factor contributing to market growth is the rising technological advancements that have enabled the development of advanced microbial identification methods and improved antibiotic susceptibility testing.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
AI Agents in Healthcare Market by Function (Scheduling, Billing, Diagnostic, Treatment, RPM, Telehealth), Offering (Multi-Agent), Architecture (Contextual, Conversational), End User (Hospital, ACS, Imaging Center), Trends, Growth - Global Forecast to 2030
The global AI Agents in Healthcare market, valued at US$0.76 billion in 2024, stood at US$1.11 billion in 2025 and is projected to advance at a resilient CAGR of 44.1% from 2025 to 2030, culminating in a forecasted valuation of US$6.92 billion by the end of the period. Advances in generative AI, natural language processing, and seamless integration with electronic health records (EHRs) are enabling AI agents to handle a range of tasks, from patient engagement and appointment scheduling to clinical decision support and documentation assistance.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Medical Immersive Simulation Market by Tech (VR, AR, Haptics VR, AI), Offering (Hardware, Software, Services), Application (Medical, Procedural, Surgery, Emergency, Anatomy, Diagnostic), End User (Academic Institutes, Hospitals) - Global Forecast to 2030
The global medical immersive simulation market is projected to reach USD 1.37 billion by 2030, growing at a CAGR of 12.3% during the forecast period (2025–2030). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030
The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
